3:25-cv-19038 ABBVIE INC. et al v. MACLEODS PHARMACEUTICAL LTD. et al
Answer to Counterclaim ( 33
The case of ABBVIE INC. et al v. MACLEODS PHARMACEUTICAL LTD. et al is a civil lawsuit with an unknown court. The docket number is 25-cv-19038. The current summary is that the defendants have filed an answer to the counterclaim. The case type is civil, and the risk assessment is that the case may involve complex issues related to intellectual property and pharmaceuticals.
No timeline activity recorded yet. This page will grow as rulings and filings land.
Court
Court not identified
Awaiting court metadata
Docket
Not captured
Civil
Stage
Active litigation
Active
Filed
Date unavailable
Not in the available feed
Latest Filing
3:25-cv-19038 ABBVIE INC. et al v. MACLEODS PHARMACEUTICAL LTD. et al
Other · Apr 24, 2026
Coverage
1 article
1 source tracked
Participants
1 Defendant
2 linked entities
Judge
Not assigned in feed
The court metadata has not been resolved yet, so Juryvine is keeping the page conservative until a reliable court match lands.
The newest docket activity we have is a other dated April 24, 2026.
The visible party/entity graph currently includes MACLEODS PHARMACEUTICAL LTD and others.
Press monitoring has found 1 related article from 1 distinct source.
ABBVIE INC. et al v. MACLEODS PHARMACEUTICAL LTD. et al is an active civil matter under docket 25-cv-19038.
The dispute currently identifies 3:25-cv-19038 ABBVIE INC on one side and MACLEODS PHARMACEUTICAL LTD on the other. The case is currently organized around Current docket activity and next procedural step, Real-estate, land-use, or property disputes, Federal jurisdiction and procedural posture, Intellectual-property ownership and infringement.
The case of ABBVIE INC. et al is a civil lawsuit with an unknown court. The docket number is 25-cv-19038.
The current summary is that the defendants have filed an answer to the counterclaim. The case type is civil, and the risk assessment is that the case may involve complex issues related to intellectual property and pharmaceuticals.
On April 24, 2026, the docket recorded a other: Abbvie Inc. and other plaintiffs filed an answer to the counterclaim in the ongoing lawsuit against Macleods Pharmaceutical Ltd. and other defendants.
The answer is a formal response to the counterclaim, which was previously filed by the defendants. This.
The next thing to watch is whether the latest other produces a substantive order, a scheduling change, a settlement signal, or a filing that clarifies the parties' positions.
Abbvie Inc. and other plaintiffs filed an answer to the counterclaim in the ongoing lawsuit against Macleods Pharmaceutical Ltd. and other defendants. The answer is a formal response to the counterclaim, which was previously filed by the defendants. This development indicates that the plaintiffs are actively engaging with the counterclaim and preparing for the next stage of the litigation.
Answer to Counterclaim ( 33
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
2 days, 8 hours ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.